Epsilon Healthcare Valuation
EPN Stock | 0.02 0.00 0.00% |
Epsilon Healthcare seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Epsilon Healthcare from reviewing the firm fundamentals such as Current Valuation of 9.69 M, profit margin of (0.82) %, and Shares Owned By Institutions of 0.03 % as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 0.7868 | Enterprise Value 9.7 M | Enterprise Value Ebitda (3.02) | Price Sales 0.9994 | Enterprise Value Revenue 1.3432 |
Overvalued
Today
Please note that Epsilon Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Epsilon Healthcare is based on 3 months time horizon. Increasing Epsilon Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Epsilon Healthcare's intrinsic value may or may not be the same as its current market price of 0.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.024 | Real 0.0202 | Hype 0.024 |
The intrinsic value of Epsilon Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Epsilon Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Epsilon Healthcare helps investors to forecast how Epsilon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Epsilon Healthcare more accurately as focusing exclusively on Epsilon Healthcare's fundamentals will not take into account other important factors: Epsilon Healthcare Cash |
|
Epsilon Healthcare Total Value Analysis
Epsilon Healthcare is currently estimated to have takeover price of 9.69 M with market capitalization of 7.21 M, debt of 3.2 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Epsilon Healthcare fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
9.69 M | 7.21 M | 3.2 M |
Epsilon Healthcare Investor Information
About 40.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Epsilon Healthcare recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Epsilon Healthcare's historical financial statements, Epsilon Healthcare is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Epsilon Healthcare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Epsilon Healthcare has an asset utilization ratio of 34.69 percent. This implies that the Company is making USD0.35 for each dollar of assets. An increasing asset utilization means that Epsilon Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.Epsilon Healthcare Ownership Allocation
Epsilon Healthcare holds a total of 300.35 Million outstanding shares. Epsilon Healthcare retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Epsilon Healthcare Profitability Analysis
The company reported the revenue of 7.11 M. Net Loss for the year was (13.29 M) with profit before overhead, payroll, taxes, and interest of 1.24 M.About Epsilon Healthcare Valuation
The stock valuation mechanism determines Epsilon Healthcare's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Epsilon Healthcare based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Epsilon Healthcare. We calculate exposure to Epsilon Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Epsilon Healthcare's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | -2.8 M | -2.6 M |
Additional Tools for Epsilon Stock Analysis
When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.